| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | -0.037 | 0.5 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.5 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.5 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.5 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |